CEO: Dipal Doshi
Employees: 183
IPO: Oct 29, 2021
Price
$13.48
Change
▲ $0.86
6.81%
Mkt Cap
516.07M
Day Range
$12.58
$13.66
52-Week Range
$4.93
$13.66
Volume
257,064
50D / 200D Avg
$11.74
$8.49
Prev Close
$12.62
Quick Summary
Key Takeaways
Earnings declined -319.04% over the past year
Debt/Equity of 0.17 — conservative balance sheet
Negative free cash flow of -129.55M
PEG of 0.01 suggests growth is underpriced
Capital efficient — spends only 4.10% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-87.94%
Earnings (1Y)-319.04%
FCF Growth (3Y)N/A
Quality
Return on Equity
-39.13%
Below sector avg (3.61%)
ROIC-32.77%
Net Margin-565.48%
Op. Margin-613.66%
Safety
Debt / Equity
0.17
Below sector avg (0.23)
Current Ratio12.53
Interest Coverage0.00
Valuation
P/E Ratio
-3.59
Below sector avg (0.23)
Forward P/EN/A
P/B Ratio1.69
EV/EBITDAN/A
Dividend Yield0.00%
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (638 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.6 | 0.2 |
| P/B | 1.7 | 2.9 |
| ROE % | -39.1 | 3.6 |
| Net Margin % | -565.5 | 3.9 |
| Rev Growth 5Y % | — | 9.6 |
| D/E | 0.2 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -87.94% | Revenue Growth (3Y) | -55.61% |
| Earnings Growth (1Y) | -319.04% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25.42M | Net Income (TTM) | -143.75M |
| ROE | -39.13% | ROA | -38.09% |
| Gross Margin | 83.89% | Operating Margin | -613.66% |
| Net Margin | -565.48% | Free Cash Flow (TTM) | -129.55M |
| ROIC | -32.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 12.53 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.59 | Forward P/E | N/A |
| P/B Ratio | 1.69 | P/S Ratio | 20.30 |
| PEG Ratio | 0.01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -25.10% | ||
| Market Cap | 516.07M | Enterprise Value | 476.61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.42M | 210.78M | 129.01M | 0.0 | 0.0 |
| Net Income | -143.75M | 65.63M | -6.69M | -94.62M | -51.16M |
| EPS (Diluted) | -3.47 | 1.68 | -0.20 | -2.79 | -1.60 |
| Gross Profit | 21.33M | 210.78M | 129.01M | 0.0 | 0.0 |
| Operating Income | -156.00M | 47.01M | -3.16M | -97.25M | -51.13M |
| EBITDA | -142.40M | 50.78M | -321,000.0 | -95.35M | -50.01M |
| R&D Expenses | 142.27M | 125.31M | 99.88M | 66.61M | 35.93M |
| SG&A Expenses | 41.05M | 38.47M | 32.29M | 30.64M | 15.20M |
| D&A | 425,000.0 | 3.77M | 2.84M | 1.90M | 1.12M |
| Interest Expense | 0.0 | 0.0 | 0.0 | 2.63M | 0.0 |
| Income Tax | 924,000.0 | 859,000.0 | 18.74M | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 377.38M | 526.32M | 469.19M | 252.06M | 305.83M |
| Total Liabilities | 71.25M | 97.64M | 226.83M | 39.50M | 7.12M |
| Shareholders' Equity | 306.13M | 428.68M | 242.36M | 212.55M | 298.72M |
| Total Debt | 50.93M | 59.21M | 68.23M | 25.94M | 0.0 |
| Cash & Equivalents | 90.39M | 101.21M | 67.60M | 45.16M | 291.06M |
| Current Assets | 306.25M | 440.04M | 369.77M | 209.88M | 298.70M |
| Current Liabilities | 24.45M | 39.48M | 158.80M | 21.97M | 6.72M |